Single-nucleus RNA/ATAC-seq in early-stage HCM models predicts SWI/SNF-activation in mutant-myocytes, and allele-specific differences in fibroblasts

Tilo Thottakara,Arun Padmanabhan,Talha Tanriverdi,Tharika Thambidurai,Jose A. Diaz-RG,Sanika R. Amonkar,Jeffrey E. Olgin,Carlin S. Long,M. Roselle Abraham

DOI: https://doi.org/10.1101/2024.04.24.589078

2024-04-24

Abstract:Hypertrophic cardiomyopathy (HCM) is associated with phenotypic variability. To gain insights into transcriptional regulation of cardiac phenotype, single-nucleus linked RNA-/ATAC-seq was performed in 5-week-old control mouse-hearts (WT) and two HCM-models (R92W-TnT, R403Q-MyHC) that exhibit differences in heart size/function and fibrosis; mutant data was compared to WT. Analysis of 23,304 nuclei from mutant hearts, and 17,669 nuclei from WT, revealed similar dysregulation of gene expression, activation of AP-1 TFs (FOS, JUN) and the SWI/SNF complex in both mutant ventricular-myocytes. In contrast, marked differences were observed between mutants, for gene expression/TF enrichment, in fibroblasts, macrophages, endothelial cells. Cellchat predicted activation of pro-hypertrophic IGF-signaling in both mutant ventricular-myocytes, and profibrotic TGFβ-signaling only in mutant-TnT fibroblasts. In summary, our bioinformatics analyses suggest that activation of IGF-signaling, AP-1 TFs and the SWI/SNF chromatin remodeler complex promotes myocyte hypertrophy in early-stage HCM. Selective activation of TGFβ-signaling in mutant-TnT fibroblasts contributes to genotype-specific differences in cardiac fibrosis.

Bioinformatics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the transcriptional regulatory mechanisms of cardiac phenotypic heterogeneity in the early stage of hypertrophic cardiomyopathy (HCM). Specifically, through single - nucleus RNA/ATAC sequencing in two HCM mouse models (R92W - TnT and R403Q - MyHC), the researchers explored gene expression changes, chromatin remodeling in mutant cardiomyocytes, and interactions between different cell types, with particular attention to the activation of the SWI/SNF complex and allele - specific differences in fibroblasts.

### Main research questions:
1. **Changes in gene expression and chromatin accessibility**: The researchers hope to reveal changes in gene expression and chromatin accessibility in cardiomyocytes and other cardiac cell types (such as fibroblasts, macrophages, endothelial cells, and vascular smooth muscle cells) in the early stage of HCM through single - nucleus RNA/ATAC sequencing.
2. **Activation of transcription factors and chromatin - remodeling complexes**: Explore the activation of AP - 1 transcription factors and SWI/SNF, ISWI chromatin - remodeling complexes in mutant cardiomyocytes.
3. **Changes in cell - to - cell communication**: Analyze the interactions between different cell types, especially the signal transduction between cardiomyocytes and other cell types, to understand how these interactions affect the phenotypic heterogeneity of HCM.
4. **Genotype - specific differences**: Compare the differences between the two HCM models (R92W - TnT and R403Q - MyHC), especially gene expression and transcription factor enrichment in fibroblasts.

### Research background:
- **Clinical manifestations of HCM**: HCM is a common inherited cardiomyopathy, and its clinical manifestations are highly heterogeneous, including left ventricular hypertrophy (LVH), cardiac dysfunction, arrhythmia, etc.
- **Uncertainty of molecular mechanisms**: Although many pathogenic variants are known to affect the structural proteins of cardiomyocytes, it is not entirely clear how these variants lead to different clinical phenotypes.
- **Necessity of research in the early disease stage**: Since early - stage HCM patients usually do not have clinical indications for cardiac biopsy or surgery, it is particularly important to use animal models to study the molecular mechanisms in the early stage.

### Research methods:
- **Single - nucleus RNA/ATAC sequencing**: Perform single - nucleus RNA and ATAC sequencing on the hearts of 5 - week - old wild - type and HCM mice to obtain data on gene expression and chromatin accessibility.
- **Bioinformatics analysis**: Use multiple bioinformatics tools (such as ArchR, SCENIC, Gene Ontology, Ingenuity Pathway Analysis, etc.) for data analysis to identify changes in gene expression, transcription factor enrichment, and cell - to - cell communication.

### Expected results:
- **Common changes in cardiomyocytes**: It is expected to observe similar gene expression changes and activation of chromatin - remodeling complexes in the two mutant cardiomyocytes.
- **Differences in non - cardiomyocytes**: It is expected to observe significant differences in gene expression and chromatin accessibility in fibroblasts, macrophages, endothelial cells, and vascular smooth muscle cells.
- **Changes in cell - to - cell communication**: It is expected to observe different signal transduction patterns between mutant cardiomyocytes and other cell types, especially signal pathways related to fibrosis and myocardial hypertrophy.

Through these studies, the paper aims to provide new insights into the early molecular mechanisms of HCM and a theoretical basis for the development of precision treatment strategies.